The Truth About NR and Cancer Risk: What Peter Attia Says

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

The Truth About NR and Cancer Risk: What Peter Attia Says.

# The Truth About NR and Cancer Risk: What Peter Attia Says

Nicotinamide Riboside (NR) has become a staple supplement in the longevity community. But with growing chatter online — “Does NR increase cancer risk?” — it’s time to cut through the noise. Peter Attia, one of the most trusted voices in longevity medicine, has addressed this concern head-on. The short answer: current evidence, including Attia’s interpretation of the science, does not support a significant cancer risk from NR at typical dosing. Let’s break down why this fear exists, what the science actually says, and how you can approach NR supplementation safely.

Why People Worry: The Cancer Connection to NAD+ Precursors

NR is a NAD+ precursor. NAD+ (nicotinamide adenine dinucleotide) is a central molecule in cellular metabolism, DNA repair, and mitochondrial function. As we age, NAD+ levels naturally decline, and NR supplementation boosts NAD+ to counteract this.

The cancer concern arises because some tumors have high NAD+ metabolism to fuel their rapid growth. The fear is that by supplying more NAD+ precursors like NR, we might “feed” potential cancer cells or accelerate tumor progression.

This concern isn’t baseless—some cancer cells upregulate enzymes like NAMPT to recycle NAD+ aggressively. But that’s a far cry from NR supplementation causing cancer in healthy cells or people.

Peter Attia’s Take: Parsing the Science and Data

Peter Attia has reviewed the literature extensively and discussed it publicly, including on his podcast and blog. His view is nuanced: NR supplementation in typical doses (100-300 mg/day) doesn’t appear to increase cancer risk in healthy individuals.

Here’s why:

  • Preclinical vs. Clinical Data: Some mouse studies show that NAD+ metabolism can support tumor growth once cancer is established. But these models often involve artificially induced tumors or extremely high NR doses (5x-10x typical human equivalent). Human data is lacking.
  • No Evidence of NR-Induced Tumorigenesis: To date, no clinical trials or epidemiological data link NR supplementation to increased cancer incidence. In fact, NAD+ plays a role in DNA repair through PARP enzymes, which theoretically could suppress cancer initiation.
  • Context Matters: If you have an active, diagnosed cancer, manipulating NAD+ metabolism might affect tumor biology. But for healthy users or those focused on prevention, the benefits of boosting NAD+—improved mitochondrial function, metabolic health, and resilience—outweigh hypothetical risks.

    • Attia emphasizes that blanket fear around NR and cancer is driven by misunderstanding the difference between correlation and causation, and the complex role of NAD+ in biology.

    Mechanism: How NR Works and Why It’s Not a Tumor Fuel

    NR converts into NAD+ via the salvage pathway. NAD+ is critical for energy production (via oxidative phosphorylation), DNA repair, and regulating sirtuins—proteins linked to longevity and cell stress responses.

    In cancer cells, NAD+ demand spikes because of uncontrolled proliferation. They often increase NAMPT expression, the rate-limiting step in NAD+ salvage, making them more dependent on NAD+ recycling.

    NR supplementation bypasses NAMPT and provides an alternative route to NAD+, but this does not specifically target cancer cells. It boosts NAD+ systemically, benefiting normal cells’ metabolism and repair mechanisms.

    If anything, NR may enhance cellular defense against DNA damage, reducing mutational burden—a key driver of cancer. So the mechanism suggests NR supports healthy cell function rather than indiscriminately feeding tumor growth.

    Typical NR Dosing and What Peter Attia Uses

    Most NR supplements come in 100 mg or 250 mg capsules. Clinical trials for metabolic and age-related conditions often use 250 mg to 300 mg daily, sometimes split into two doses.

    Peter Attia has mentioned using NR around 250 mg/day in his personal regimen, sometimes combined with other NAD+ precursors like NMN or low-dose nicotinamide. This dosing consistently raises NAD+ levels by 30-50% without adverse effects.

    There’s no benefit to mega-dosing NR (above 500-1000 mg/day), and higher doses haven’t been proven safer or more effective. Stick to doses supported by human studies.

    Side Effects and What to Watch For

    NR is generally well tolerated. Some people report mild flushing or nausea at high doses, but serious adverse effects are rare.

    Regarding cancer risk, there are no red flags in human data. However, if you have an active malignancy or a high hereditary cancer risk, consult your oncologist before starting NR.

    Monitor for any unusual symptoms, but don’t let fear of cancer be the default reason to avoid NR if you’re otherwise healthy.

    Who Should Consider NR and Who Should Be Cautious

    NR is best suited for people interested in mitochondrial health, metabolic support, and longevity optimization—especially those over 40 where NAD+ decline impacts energy and repair.

    If you’re undergoing cancer treatment or have an active tumor, NR supplementation should be approached cautiously and only under medical supervision.

    People with genetic predispositions to cancer (e.g., BRCA mutations) should weigh the pros and cons carefully and discuss with a specialist.

    Practical Takeaway: Use NR with Confidence, Not Fear

    NR supplementation at 100-300 mg/day safely boosts NAD+ levels, supporting metabolism and DNA repair without clear evidence of increasing cancer risk in healthy individuals.

    Peter Attia’s stance is clear: don’t let unsubstantiated cancer fears stop you from using NR if you’re seeking its longevity benefits. The mechanisms and data suggest NR helps maintain cellular health rather than promoting tumor growth.

    If cancer risk is a specific concern due to personal or family history, get a thorough evaluation but don’t assume NR is contraindicated by default.

    ---

    If you’re considering NR, start with 250 mg/day, observe how you feel, and combine it with a healthy lifestyle—exercise, nutrition, sleep—which together reduce cancer risk far more than any single supplement can increase it.

    Talk to your doctor if you have active cancer or hereditary risks, but for most people, NR is a valuable tool in the longevity toolkit, not a cancer catalyst.